MedTrace Logo

Bronchoprotection of Salbutamol in Asthma and Chronic Obstructive Pulmonary Disease

NCT00440245 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 28

Last updated 2020-03-27

No results posted yet for this study

Summary

This study will investigate potential differences in how two puffs of salbutamol protects airway smooth muscle from contracting in people with asthma and chronic obstructive pulmonary disease (COPD).

Conditions

Interventions

DRUG

salbutamol

200 micrograms salbutamol from MDI

Sponsors & Collaborators

  • University of Saskatchewan

    lead OTHER

Principal Investigators

  • Donald Cockcroft, MD · University of Saskatchewan

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-02-28
Primary Completion
2010-07-31
Completion
2010-07-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00440245 on ClinicalTrials.gov